国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Traditional Medicine Treatment for Alzheimer?s

Joshi Hanumanthachar

Alzheimer’s disease (AD) is one of the most common conditions in elderly people with a high prevalence of dementia at roughly 60 – 80. The pathogenesis of AD was relatively complicated and presently there's no unified conclusion in the academic community, so no efficiently clinical treatment is available. In recent years, with the development of traditional Chinese drug (TCM), experimenters have proposed the idea of relying on TCM to prevent and treat AD based on the specific of multiple targets of TCM. This study reviewed the pathological thesis of AD and the implicit biomarkers set up in the current researches. And the implicit targets of berberine and evodiamine from Evodia rutaecarpa in AD were summarized and further anatomized. A emulsion- targets- pathway network was carried out to clarify the medium of action of berberine and evodiamine for AD. Likewise, the limitations of current inquiries on the TCM and AD were discussed. It's hoped that this review will give some references for development of TCM in the prevention and treatment of AD.